Literature DB >> 21857235

Current practice and opinions regarding the use of oropharyngeal throat packs in the United Kingdom.

Brian Bisase1, Nigel Shaun Matthews, Cindy Lan.   

Abstract

OBJECTIVE: : The aim of this study was to establish the current practice and opinions regarding responsibilities when using OPTPs in the United Kingdom.
METHODS: : A total of 330 anonymous questionnaires exploring the use, attitudes, opinions, and experiences of surgeons (n = 180) and anesthetists (n = 150) were disseminated.
RESULTS: : The response rate was 82%. Just less than one-third of surgeons and just more than one-third of anesthetists rarely or never use OPTP. Just more than half of the surgeons responding were aware of 1 to 4 nonfatal adverse events. Two surgeons and 1 anesthetist were aware of 1 to 4 fatalities relating to a retained OPTP. There was a marked difference in opinions regarding OPTP removal and whose ultimate responsibility it is to remove.
CONCLUSIONS: : The use of the OPTP is not routine in the United Kingdom, and adverse incidents occasionally occur when used. It would also seem that, despite the recent publicity and advice documents during the last few years, theater teams may still be at variance with regard to related responsibilities. As such, although objective data emerge, we support a unified practice and policy at the Trust and national level that all teams should adhere to when appropriate.

Mesh:

Year:  2011        PMID: 21857235     DOI: 10.1097/PTS.0b013e31822e8194

Source DB:  PubMed          Journal:  J Patient Saf        ISSN: 1549-8417            Impact factor:   2.844


  2 in total

1.  Pharyngeal Packing during Rhinoplasty: Advantages and Disadvantages.

Authors:  Majid Razavi; Mehryar Taghavi Gilani; Ali Reza Bameshki; Reza Behdani; Ehsan Khadivi; Mahdi Bakhshaee
Journal:  Iran J Otorhinolaryngol       Date:  2015-11

2.  The use of throat packs in pediatric cleft lip/palate surgery: a retrospective study.

Authors:  B J A Smarius; C H A L Guillaume; G Jonker; A B Mink van der Molen; C C Breugem
Journal:  Clin Oral Investig       Date:  2018-02-22       Impact factor: 3.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.